4//SEC Filing
SCHADE CHRISTIAN S 4
Accession 0001104659-22-062916
CIK 0001781983other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:30 PM ET
Size
10.9 KB
Accession
0001104659-22-062916
Insider Transaction Report
Form 4
SCHADE CHRISTIAN S
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2022-05-18$0.64/sh+37,500$24,124→ 292,616 total
Holdings
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 5,000(indirect: By Spouse)
Common Stock
- 1,000(indirect: By Children)
Common Stock
- 1,000(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.6245 to $0.6675, inclusive. The reporting person undertakes to provide Aprea Therapeutics, Inc., any security holder of Aprea Therapeutics, Inc., or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001214496
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:30 PM ET
- Size
- 10.9 KB